MIRATI THERAPEUTICS INC MRTX
COM · Common Stock · CUSIP 60468T105 · ISIN US60468T1051
2
institutional holders
-216 vs Q4 2023
43
shares reported held*
$2.5kreported value*
0 new
0 added
1 reduced
211 sold out
net sold ≈ $4.7bn (-79.6m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $58.72.
Trends to Q1 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 244 |
| Q4 2022 | 233 |
| Q1 2023 | 223 |
| Q2 2023 | 208 |
| Q3 2023 | 215 |
| Q4 2023 | 218 |
| Q1 2024 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 133 | 118 |
| Q1 2023 | 119 | 104 |
| Q2 2023 | 106 | 108 |
| Q3 2023 | 137 | 88 |
| Q4 2023 | 120 | 130 |
| Q1 2024 | 0 | 212 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2023 | $33.6m | $11.3m | 0.34 |
| Q3 2023 | $75.7m | $23.3m | 0.31 |
| Q4 2023 | $87.7m | $103.4m | 1.18 |
| Q1 2024 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| MORGAN STANLEY | Sold out | -12.3m |
| EcoR1 Capital, LLC | Sold out | -7.4m |
| RTW INVESTMENTS, LP | Sold out | -6.8m |
| VANGUARD GROUP INC | Sold out | -5.3m |
| Avoro Capital Advisors LLC | Sold out | -4.9m |
| BAKER BROS. ADVISORS LP | Sold out | -4.1m |
| BlackRock Inc. | Sold out | -3.9m |
| Boxer Capital, LLC | Sold out | -3.2m |
| Braslyn Ltd. | Sold out | -3.1m |
| STATE STREET CORP | Sold out | -2.3m |
Holders, Q1 2024
| Manager | Shares | Change |
|---|---|---|
| Sachetta, LLC 0.00% of their portfolio | 24 $1.4k | Unchanged |
| IFP Advisors, Inc 0.00% of their portfolio | 19 $1.1k | Reduced -3.7k |